Enterome raises €10m series-B

Seventure invested via the Health for Life Capital fund, which launched in December 2013 with a target of €120m. The vehicle focuses on investments in health nutrition in Europe, North America and Asia.

Enterome will use the fresh funding to support R&D efforts. 

Seventure and Lundbeckfond initially backed the firm in 2012 in a €5m series-A round. The company raised a €1.5m seed capital fund from Seventure and consulting company INRA Transfert prior to that. Enterome has raised €17.5m to date. 

Company
Founded in 2012 and based in Paris, Enterome develops biomarkers and diagnostics for inflammatory bowel diseases and metabolic disorders involving the gut microbiome. The company will later develop therapeutics in the area. 

Enterome's technology was initially developed at the INRA (Institut National de la Recherche Agronomique) in Jouy-en-Josas.

People
Isabelle de Cremoux is the CEO of Seventure. Johan Kordel is a senior partner at Lundbeckfond Ventures. 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Healthcare
• Early-stage
• France
• Seventure (SPEF)
• Omnes Capital